Dendrite Announces Management Changes.

Business Editors

MORRISTOWN, N.J.--(BUSINESS WIRE)--June 14, 2001

Dendrite (NASDAQ/NMS: DRTE) today announced a series of management changes.

Michael G. Atieh, Senior Vice President and Chief Financial Officer will be taking a leave of absence from the company effective June 15, 2001. In mid-May, Mr. Atieh informed Dendrite of his decision to leave the CFO position and take a leave of absence. At that time the company began a search to fill the CFO position and to transition the oversight of Mr. Atieh's responsibilities to George T. Robson, Executive Vice President and prior CFO of the company. Mr. Robson, who originally had planned to retire in mid-2001, will coordinate the search for the new CFO and will delay his retirement to ensure continued strong financial management and a smooth transition. Mr. Atieh intends to return to the company during the fourth quarter of 2001.

The company also announced that Brent Cosgrove has been promoted to Vice President and Corporate Controller. Mr. Cosgrove has been with Dendrite for 5 years and previously served as Director of Accounting, European Controller, and most recently as Director of Investor Relations for the company.

About Dendrite

Dendrite, the visionary innovator in global pharmaceutical technology, helps clients strategically manage their customer relationships to increase market share. For more information, visit the company's website at http://www.dendrite.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

The foregoing contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The statements may be identified by such forward-looking terminology as "expect," "believe," "may," "will," "intend," "plan," and similar statements or variations. Such forward-looking statements are based on our current estimates and assumptions and involve certain significant risks and uncertainties, including: risks associated with and dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy selling cycles, product implementation cycles, customer budget cycles, and timing of revenue recognition; dependence on major customers; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; retention of key senior managers; and unique characteristics of the consumer packaged goods industry. Other important factors that should be considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements.